HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 – Clinical Trial Not Allowed). This notice of funding opportunity (NOFO) aims to encourage research grant applications for initial translational efforts that will enable a drug discovery program for novel, non-opioid, and non-addictive treatments for pain. The goal of this NOFO is to advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program or other later-stage translational programs. Preliminary in vivo pharmacokinetic, pharmacodynamic, and efficacy studies may also be supported.
Posted 9/18/24. LOI due 30 days prior to the application due date. Expires 1/16/27.